References 1. Ischiropoulos H, Beckman JS (2003) Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111: 163–169. 2. Zou MH, Cohen R, Ullrich V (2004) Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11: 89–97. 3. Radi R (2004) Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A 101: 4003–4008. 4. Baker PR, Lin Y, Schopfer FJ, Woodcock SR, Groeger AL, et al. (2005) Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J Biol Chem 280: 42464–42475. 5. Villacorta L, Zhang J, Garcia-Barrio MT, Chen XL, Freeman BA, et al. (2007) Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway. Am J Physiol Heart Circ Physiol 293: H770–776. 6. Freeman BA, Baker PR, Schopfer FJ, Woodcock SR, Napolitano A, et al. (2008) Nitro-fatty acid formation and signaling. J Biol Chem 283(23): 15515–9. 7. Lima ES, Di Mascio P, Rubbo H, Abdalla DS (2002) Characterization of linoleic acid nitration in human blood plasma by mass spectrometry. Biochemistry 41: 10717–10722. 8. Halliwell B (2000) Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc Res 47: 410–418. 9. Lima ES, Di Mascio P, Abdalla DS (2003) Cholesteryl nitrolinoleate, a nitrated lipid present in human blood plasma and lipoproteins. J Lipid Res 44: 1660–1666. 10. Hayashi K, Noguchi N, Niki E (1995) Action of nitric oxide as an antioxidant against oxidation of soybean phosphatidylcholine liposomal membranes. FEBS Lett 370: 37–40. 11. Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, et al. (2003) AMP- activated protein kinase, super metabolic regulator. Biochem Soc Trans 31: 162–168. 12. Kahn BB, Alquier T, Carling D, Hardie DG (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15–25. 13. Hawley SA, Selbert MA, Goldstein EG, Edelman AM, Carling D, et al. (1995) 59-AMP activates the AMP-activated protein kinase cascade, and Ca2+/ calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 270: 27186–27191. 14. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, et al. (2003) Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/ beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2: 28. 15. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, et al. (2005) The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280: 29060–29066. 16. Zou MH, Wu Y (2008) AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function. Clin Exp Pharmacol Physiol 35: 535–545. 17. Hattori Y, Suzuki K, Hattori S, Kasai K (2006) Metformin inhibits cytokine- induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 47: 1183–1188. 18. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, et al. (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP- activated protein kinase. J Biol Chem 271: 27879–27887. 19. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, et al. (2003) LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13: 2004–2008. 20. Ziello JE, Jovin IS, Huang Y (2007) Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med 80: 51–60. 21. Taylor CT (2008) Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J 409: 19–26. 22. Wenger RH (2002) Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. Faseb J 16: 1151–1162. 23. Brahimi-Horn C, Mazure N, Pouyssegur J (2005) Signalling via the hypoxia- inducible factor-1alpha requires multiple posttranslational modifications. Cell Signal 17: 1–9. 24. Wang J, Semenza G, Sylvester JT, Shimoda LA (2005) HIF-1 regulates hypoxic- induction of canonical transient receptor potential (TRPC) channels in pulmonary arterial smooth muscle cells. Faseb J 19: A1278. 25. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, et al. (2005) Calmodulin- dependent protein kinase kinase-beta is an alternative upstream kinase for AMP- activated protein kinase. Cell Metab 2: 9–19. 26. Zou MH, Hou XY, Shi CM, Nagata D, Walsh K, et al. (2002) Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphor- ylation of endothelial nitric oxide synthase. J Biol Chem 277: 32552–32557. 27. Zhang Y, Lee TS, Kolb EM, Sun K, Lu X, et al. (2006) AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. Arterioscler Thromb Vasc Biol 26: 1281–1287. AMPK-Dependent Angiogenesis by Nitrated Lipids 28. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, et al. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601–605. 29. Coles B, Bloodsworth A, Clark SR, Lewis MJ, Cross AR, et al. (2002) Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ Res 91: 375–381. 30. Bussolati B, Ahmed A, Pemberton H, Landis RC, Di Carlo F, et al. (2004) Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103: 761–766. 31. Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, et al. (1998) Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4: 1073–1077. 32. Willis D, Moore AR, Frederick R, Willoughby DA (1996) Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 2: 87–90. 33. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ (1997) Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 100: 1209–1216. 34. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, et al. (1999) Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129–135. 35. Poss KD, Tonegawa S (1997) Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 94: 10919–10924. 36. Soares MP, Brouard S, Smith RN, Bach FH (2001) Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs. Immunol Rev 184: 275–285. 37. Motterlini R, Foresti R, Intaglietta M, Winslow RM (1996) NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 270: H107–114. 38. Polte T, Oberle S, Schroder H (1997) The nitric oxide donor SIN-1 protects endothelial cells from tumor necrosis factor-alpha-mediated cytotoxicity: possible role for cyclic GMP and heme oxygenase. J Mol Cell Cardiol 29: 3305–3310. 39. Deramaudt BM, Braunstein S, Remy P, Abraham NG (1998) Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 68: 121–127. 40. Wright MM, Schopfer FJ, Baker PR, Vidyasagar V, Powell P, et al. (2006) Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression. Proc Natl Acad Sci U S A 103: 4299–4304. 41. Liu XM, Peyton KJ, Shebib AR, Wang H, Korthuis RJ, et al. (2011) Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol 300: H84–93. 42. Sutter CH, Laughner E, Semenza GL (2000) Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc Natl Acad Sci U S A 97: 4748–4753. 43. Dulak J, Deshane J, Jozkowicz A, Agarwal A (2008) Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117: 231–241. 44. Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, et al. (2007) Hypoxia- inducible factor 1alpha stabilization by carbon monoxide results in cytoprotec- tive preconditioning. Proc Natl Acad Sci U S A 104: 5109–5114. 45. Aley PK, Porter KE, Boyle JP, Kemp PJ, Peers C (2005) Hypoxic modulation of Ca2+ signaling in human venous endothelial cells. Multiple roles for reactive oxygen species. J Biol Chem 280: 13349–13354. 46. Stahmann N, Woods A, Carling D, Heller R (2006) Thrombin activates AMP- activated protein kinase in endothelial cells via a pathway involving Ca2+/ calmodulin-dependent protein kinase kinase beta. Mol Cell Biol 26: 5933–5945. 47. da Silva CG, Jarzyna R, Specht A, Kaczmarek E (2006) Extracellular nucleotides and adenosine independently activate AMP-activated protein kinase in endothelial cells: involvement of P2 receptors and adenosine transporters. Circ Res 98: e39–47. 48. Mount PF, Lane N, Venkatesan S, Steinberg GR, Fraser SA, et al. (2008) Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK- dependent activation of AMPK. Atherosclerosis 200: 28–36. 49. Zou MH, Wu Y (2008) AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function. Clin Exp Pharmacol Physiol 34: 35(5– 6): 535–45. 50. Forstermann U, Munzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708–1714. 51. Gorczynski MJ, Huang J, King SB (2006) Regio- and stereospecific syntheses and nitric oxide donor properties of (E)-9- and (E)-10-nitrooctadec-9-enoic acids. Org Lett 8: 2305–2308. 52. Moriel P, Pereira IR, Bertolami MC, Abdalla DS (2001) Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia? Free Radic Biol Med 30: 318–326. 53. Nagata D, Mogi M, Walsh K (2003) AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 278: 31000–31006. 54. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, et al. (2004) Adiponectin stimulates angiogenesis by promoting cross-talk between AMP- PLoS ONE | www.plosone.org 10 February 2012 | Volume 7 | Issue 2 | e31056